The USP 1217 tablet breaking force test is the United States Pharmacopeia's informational chapter describing how to measure the crushing force required to fracture a tablet under diametral compression — a key physical quality attribute for every commercial tablet dosage form. The chapter, formally titled General Chapter <1217> Tablet Breaking Force, sits in the USP's informational tier (numbered above 1000) yet is cross-referenced by product monographs, referenced by FDA inspectors, and treated as the de facto mandatory method for US pharmaceutical QC labs. This guide covers every sub-section of USP <1217>, the equipment specifications the chapter implies, the test procedure step by step, the acceptance criteria typically written into tablet product specifications, and the validation documentation a lab must keep. Any QC manager, R&D formulator, or regulatory-affairs specialist preparing a tablet dossier for the US market needs to be fluent in USP <1217>.
What Is USP Chapter 1217 and Who Must Comply?
USP <1217> was added to the United States Pharmacopeia to provide a reference method and instrument-performance guidance for what the industry loosely calls "tablet hardness testing." The chapter defines tablet breaking force as the force required to cause a tablet to fracture under a slowly applied diametral compression between two opposing flat, parallel jaws. The quantity is reported in newtons (N) or, in older literature, in kiloponds (kp) or strong cobb units (the latter is legacy; modern QC labs use N exclusively).
Regulatory status
Although <1217> is informational, it is almost always invoked through product monographs and through compendial compliance language in CMC sections of INDs, NDAs, ANDAs, and DMFs. The US FDA's 21 CFR 211.110(a)(5) requires in-process controls for tablets including "hardness," and the industry convention is that "hardness" in this context means "breaking force per USP <1217>." Failure to follow the chapter without scientific justification is a routine 483 observation.
Who must comply
- US-market tablet manufacturers — branded, generic, OTC. Every batch released to the US market should carry a USP <1217> breaking-force result or an equivalent.
- Contract manufacturers (CMOs/CDMOs) producing for US MA holders.
- Contract research organizations (CROs) running stability studies or bio-equivalence batches for US submissions.
- Generic-drug sponsors — ANDAs routinely reference USP <1217> in the pharmaceutical development and in-process control sections.
- Compounding pharmacies under 503B outsourcing (though enforcement historically milder).
Research-only labs that will never feed data into an FDA submission are not strictly bound, but best practice is to validate the method per <1217> from day one.
Relationship to USP <1216> Friability
USP <1216> (Tablet Friability) and USP <1217> (Tablet Breaking Force) are complementary. A tablet can pass one and fail the other: a soft compact may have low breaking force but low friability, while an over-compacted tablet may be hard but brittle with high friability. Most QC labs run both as a pair.
Relationship to the harmonized framework
Under ICH Q4B Annex 5, USP <1217> is partially harmonized with EP 2.9.8 and JP 6.09. The key deltas (covered in the EP 2.9.8 tablet crushing strength guide) are sample size and reporting format. A lab running a single n = 10 test set, correctly documented, can satisfy all three.
Reading the Chapter — Sub-Section by Sub-Section
USP <1217> is organized into a short set of sections that together define the method. The full chapter text is available through a USP subscription; this guide summarizes the operational meaning of each section.
Introduction and scope
The chapter's opening paragraphs define the applicability: tablets and tablet-like compacts (including scored tablets, coated tablets, and caplets). It explicitly excludes capsules, orally disintegrating films, and chewable gummies. For film-coated tablets, the chapter notes that the coating may affect the measurement and that in-process hardness should be measured on the core when possible.
Apparatus
The chapter calls for an instrument capable of applying a gradually increasing force diametrally to the tablet. The apparatus must:
- Apply force via two opposing jaws that are flat, polished, parallel to each other, and perpendicular to the direction of motion.
- Move one jaw at a constant rate (or apply a constantly increasing force) while the other remains stationary.
- Measure and record the peak force at tablet fracture.
- Have a force measurement range and accuracy appropriate to the tablet strength being measured — industry practice is force readings within ±2% of the true value, though many QC labs target ±1% or better.
The chapter does not mandate a specific instrument geometry beyond these performance characteristics, which is why the same modern pharmaceutical texture analyzer — such as the KHT TA-30 — can satisfy <1217> alongside many other compendial methods.
Method
The method section describes the test sequence: place the tablet between the jaws with its longest dimension perpendicular to the direction of applied force; compress at a controlled rate; record the peak force. The chapter emphasizes tablet orientation: for oblong or caplet-shaped tablets, the tablet is placed so that the applied force acts across the minor axis. For round biconvex tablets, the flat band is placed parallel to the jaw face.
Interpretation of results
Individual tablets vary; the chapter acknowledges that breaking force is a statistical property of the batch. Results are typically reported as individual values plus mean and range. Monograph acceptance criteria are usually expressed as a mean value within a stated range (e.g., 80–150 N) or as a minimum individual value.
Equipment qualification
The chapter references USP <1058> Analytical Instrument Qualification, under which a tablet hardness tester or texture analyzer is typically classified as a Group B instrument (standard laboratory instrument; qualification focuses on calibration and functionality). Larger texture analyzers used for multiple applications can be treated as Group C (more extensive validation including software).
Equipment Requirements: Force Range, Accuracy & Calibration per USP 1217
USP <1217> states performance requirements in functional terms. Translating them into purchase specifications for a pharmaceutical texture analyzer looks like this.
Force capacity
Pharmaceutical tablets typically break at 30–200 N, with moisture-resistant or high-dose tablets reaching 300+ N. A 500 N load cell is the industry standard and covers over 90% of tablet dosage forms with comfortable headroom. For specialty products — bilayer tablets, chewables, large equine veterinary tablets — a higher-capacity cell (up to 1000 N) may be used. Using a load cell with capacity far higher than the tablet strength loses precision in the signal-to-noise region where fracture occurs.
The KHT TA-30 ships with a 500 N standard load cell and offers 5 N, 50 N, and 1000 N options, so labs can run tablet hardness on the same instrument that measures microneedle insertion force (sub-newton) and packaging puncture (hundreds of newtons).
Force accuracy and resolution
- Accuracy: ±0.5% of reading is the performance target for a well-calibrated QC instrument (better than the chapter's implicit ±2%). This ensures that measurements near specification limits are not rejected because of instrument error.
- Resolution: 0.01 N is sufficient to resolve fracture events on film-coated tablets and to compute work-of-fracture from force-distance curves.
- Linearity: Load cell must be linear across its full range, verified during OQ calibration with NIST-traceable mass standards.
Speed range
The chapter does not mandate a specific loading rate; industry practice converges on 1.0–2.0 mm/s for standard tablets. A 1 mm/s rate gives a clean peak; a 2 mm/s rate is faster for high-throughput QC. Whatever rate is chosen, it must be fixed and documented in the method. An instrument with a speed range of 0.01–40 mm/s (KHT TA-30 range: 0.001–40 mm/s) allows the lab to use the same hardware for tablet hardness, slower-speed semisolid tests, and faster-speed peel tests.
Data acquisition rate
A data-acquisition rate of at least 200 Hz is needed to capture the fracture peak accurately. Lower rates risk under-reporting the true peak force because the instant of fracture may fall between samples. A 500 Hz or higher rate is preferred, and the KHT TA-30 operates at ≥500 Hz native (compared to some budget instruments which sample at only 50–100 Hz).
Calibration traceability
USP <1058> and 21 CFR Part 211 expect NIST-traceable calibration for force measurement (via calibrated mass standards or force transducers) and NIST- or ISO-traceable for distance (via calibrated gauge blocks). A UKAS- or ISO/IEC 17025-accredited external calibration service is the common industry choice, typically on an annual cycle.
Calibration records must include:
- Date of calibration
- Reference standard used (with traceable serial numbers)
- As-found values before any adjustment
- As-left values after adjustment
- Tolerance vs. specification
- Signature of calibration technician and QC approval
Instrument qualification (IQ/OQ/PQ)
- IQ (Installation Qualification): Instrument received, inspected, installed, utilities verified (power, bench stability, environment within limits).
- OQ (Operational Qualification): Force calibration against traceable standards across the working range; speed verification; distance verification; software function verification.
- PQ (Performance Qualification): Reference tablet set run at the intended method conditions; results within pre-defined acceptance criteria; demonstrates the instrument performs as intended for the specific application.
Step-by-Step USP 1217 Test Procedure (HowTo)
The procedure below is a compliance-ready SOP skeleton; adapt to your product monograph and lab QMS.
- Verify the instrument status. Check the calibration sticker — calibration must be current. Check the audit trail for any out-of-spec events since the last use. Verify environmental conditions (21 ± 2 °C, 45 ± 15% RH typical).
- Log in under your own user ID. Do not share accounts. The 21 CFR Part 11 audit trail needs the test to be attributable.
- Install the tablet-hardness jaws. Flat, parallel, polished, hardened-steel. Verify by visual inspection and with a shim or feeler gauge that jaw parallelism is within manufacturer spec.
- Select the appropriate load cell. 500 N for standard tablets. Confirm by software interlock that the chosen load cell matches the method.
- Load the SOP-locked method. For QC release testing, methods are locked — operators cannot edit parameters. Typical parameter set: test speed 1.0 or 2.0 mm/s; return speed 10 mm/s; trigger force 0.05 N; break detection via force-drop of 40% from peak; data-acquisition rate 500 Hz.
- Prepare the tablet sample. Take at least n = 6 tablets from the batch per product monograph (some monographs require n = 10 or more). Equilibrate to lab conditions. Visually inspect; reject chipped, cracked, or laminated specimens.
- Load the first tablet. Place on the lower jaw. Orient: oblong or caplet tablets along the minor axis; round biconvex with flat band parallel to jaw face; scored tablets with the score line perpendicular to the force direction.
- Initiate the test. The upper jaw descends at the configured rate until the tablet fractures. The software captures the peak force and the force-vs-distance curve.
- Visual validation. Immediately inspect the broken tablet. Confirm a clean diametral fracture. If the tablet split laminarly, exhibited multiple peaks, or crumbled without a clear break, flag the result and investigate.
- Record the result. The software automatically records: peak force, date/time, operator ID, method version, instrument serial, load cell ID, probe ID, and the full force-distance trace.
- Repeat for all tablets. Maintain sample identity (position in batch if required).
- Compute statistics. Mean, standard deviation, minimum, maximum, range. For batches intended for EU or Japan markets, also record mean ± SD in the EP 2.9.8 format.
- Operator review and e-signature. Review individual curves, confirm data quality, apply Part 11 e-signature with meaning "Tested by."
- QC supervisor review. Independent second-person review of results and audit trail. Apply e-signature with meaning "Reviewed and approved."
- Compare to specification. Against the product monograph or internal specification: mean within limits, minimum individual value above the floor, RSD within precision target.
- Disposition. Pass or fail decision logged. If fail, invoke OOS (out-of-specification) investigation per SOP.
- Archive. Raw data, processed results, audit trail, and operator signatures retained per retention schedule (typically ≥ 5 years after product expiry).
Acceptance Criteria: Minimum Hardness, n-Value & Outlier Rules
USP <1217> itself does not prescribe numerical acceptance criteria — the chapter is a method, not a specification. Acceptance criteria are set in the product monograph, the manufacturing specification, or the stability protocol. The following practical guidance applies to most QC tablet work.
Typical hardness ranges by tablet type
| Tablet type | Typical breaking-force range (N) |
|---|---|
| Fast-disintegrating / orodispersible | 15–40 |
| Standard immediate-release | 60–120 |
| Film-coated immediate-release | 80–180 |
| Extended-release matrix | 100–250 |
| Chewable | 30–80 |
| Moisture-barrier hard-shell | 150–300 |
These ranges are indicative only; the specification for each product is set during development based on manufacturability, handling robustness (pick-and-place, bottling, blister packaging), and dissolution performance.
Sample size (n-value)
USP <1217> does not mandate a fixed n. Industry practice:
- Routine in-process control: n = 6 per sampling point, multiple sampling points per batch.
- Batch release: n = 6 or n = 10 per the product specification.
- Development, method validation: n = 30+ for statistical confidence.
- Multi-region (US + EU): n = 10 to satisfy EP 2.9.8 simultaneously.
Reporting format
Individual values plus mean, SD, and range. For multi-region compliance, also report mean ± SD per EP 2.9.8.
Outlier handling
Any individual value that falls outside the specification but is bracketed by conforming values should trigger an OOS investigation per 21 CFR 211.192. The USP Chapter <1010> framework on interpretation of analytical results applies. Common outlier causes:
- Capping or lamination (formulation or tooling issue)
- Chipped edge (handling damage)
- Off-center loading (operator technique)
- Instrument fault (investigate via audit trail and re-run after QC of instrument)
Arbitrary deletion of data is not permitted. Every excluded data point must have a documented, science-based justification.
Common Sources of Variability and How to Control Them
USP <1217> results are sensitive to operator technique, instrument configuration, and sample condition. The most common contributors to between-operator or between-lab variability — and the controls QC managers apply to suppress them — are:
Tablet orientation
The most commonly overlooked variable. For non-round tablets, a 10° rotation of the tablet on the jaw can change the measured breaking force by 20–30%. Control: the method specifies the orientation (e.g., "caplet placed with long axis perpendicular to the force direction"), and the SOP shows a photograph or diagram. Training operators to reproduce the same orientation is the single highest-return intervention.
Jaw wear and cleanliness
Jaws that accumulate tablet residue, film-coating debris, or polishing micro-scratches alter the contact geometry and can under- or over-estimate breaking force. Control: weekly visual inspection; cleaning with a lint-free wipe between batches; replacement when surface degrades. Document jaw serial number in the method.
Environmental conditioning
Tablets are hygroscopic — moisture pickup can reduce breaking force by 10–30% at elevated humidity. Control: maintain 45 ± 15% RH in the lab; equilibrate tablets to room conditions before testing; for critical specifications, use a desiccated test chamber.
Loading rate
Tablets are viscoelastic materials. Measured breaking force increases with loading rate. Control: fix the test speed in the method (typically 1.0 or 2.0 mm/s), document it, and use the same rate for all stability and release testing on the product.
Load cell range mismatch
A 500 N cell measuring a 20 N tablet loses effective resolution. Control: for orodispersible or chewable tablets, use a 50 N or 100 N cell.
Operator-to-operator variability
Despite locked methods, operators introduce variability through loading technique. Control: run an annual inter-operator comparison (each operator tests the same reference batch, n = 10); tolerate ≤ 5% RSD operator-to-operator; retrain if wider.
Common Deviations and OOS Investigation Pathway
When an individual tablet value or a batch mean falls outside the product specification, the QC lab must run an Out-of-Specification (OOS) investigation per the FDA's 2006 OOS Guidance and 21 CFR 211.192.
Phase 1 — Laboratory investigation
Before invoking a full OOS, the QC supervisor verifies:
- Was the instrument in calibration? (Audit trail check.)
- Was the method the approved version? (Method-version log.)
- Was the operator qualified and the login authentic? (User access log.)
- Was the sample representative and free of visible defects?
- Were any abnormal fracture patterns observed (lamination, capping)?
If Phase 1 identifies a clear laboratory error (wrong method, wrong sample, obvious instrument fault), the result is invalidated with documentation, the test is repeated, and the original result is retained in the audit trail but marked as invalidated.
Phase 2 — Full OOS investigation
If no laboratory error is found in Phase 1, a formal OOS opens. Typically: retest with n = 30 (or per site SOP), evaluate against specification, review manufacturing batch data, determine root cause, dispose of batch per regulatory pathway, document in a formal OOS report signed by QC and QA.
Documenting OOS in Part 11 systems
Every OOS-related action — invalidation, retest, root-cause entry, QA approval — is logged in the 21 CFR Part 11 audit trail and electronically signed. Attempting to resolve an OOS by simply deleting data or running the test a second time without documentation is a common cause of FDA 483 observations and warning letters.
Cost Considerations for USP 1217 Method Implementation
For a lab setting up a new USP <1217> capability or migrating from a legacy dedicated hardness tester to a multi-purpose texture analyzer, the typical cost lines over 5 years:
| Cost line | Enterprise-brand texture analyzer | KHT TA-30 |
|---|---|---|
| Instrument purchase | $15,000–$25,000 | $8,000–$13,000 (published) |
| 21 CFR Part 11 software | Often optional +$2,000–$5,000 | Included standard |
| IQ/OQ/PQ validation package | Often optional +$2,000–$5,000 | Included standard |
| Method template library | Sometimes optional | 30+ templates included |
| Annual calibration | $1,000–$3,000 | $800–$1,500 |
| Probe/jaw replacements | $500–$2,000/yr (proprietary) | Lower (universal interface option) |
| Software maintenance | $500–$2,000/yr | Varies; transparent |
| Training | $500–$3,000 (paid on-site) | Free 3-day onboarding library |
| 5-year TCO | $25,000–$60,000 | Target 40–60% lower |
Transparent line-item pricing is published on the KHT website rather than gated behind an inquiry form.
Calibration Schedule and Validation Maintenance
For a USP <1217> tablet hardness method on a modern pharmaceutical texture analyzer, the maintenance cadence looks like this:
| Activity | Frequency | Standard used |
|---|---|---|
| Daily check (before use) | Each shift | Known-force reference spring or calibrated tablet |
| Routine verification | Monthly | NIST-traceable calibrated mass set |
| Full calibration | Every 6–12 months | ISO/IEC 17025 accredited external service |
| Probe/jaw inspection | Weekly | Visual; replace if surface degraded |
| Software audit-trail review | Weekly or monthly | QA procedure |
| Periodic (re)validation | Every 2 years | Full method validation refresh |
How the KHT TA-30 Meets USP 1217 Requirements (Compliance Checklist)
- Flat, parallel, polished hardened-steel tablet jaws — included standard; parallelism verified at the factory and re-verified at IQ.
- 500 N standard load cell — covers 90%+ of tablet products; additional 5 N, 50 N, 1000 N cells available.
- Force accuracy ±0.5% of reading — exceeds USP <1217> implicit requirements.
- Speed range 0.001–40 mm/s — configurable anywhere in the compendial 1–2 mm/s window and beyond.
- Data-acquisition rate ≥ 500 Hz — captures fracture event cleanly; higher than Enterprise mid-tier competitors' 500 Hz maximum.
- NIST-traceable calibration service — available at purchase and on the annual cycle.
- USP <1058> Group B/C ready — IQ/OQ/PQ protocols delivered with every instrument.
- 21 CFR Part 11 software native — audit trail, e-signature, role-based access standard — not a paid upgrade.
- USP <1217> method template pre-loaded — operator loads, runs, reviews; no method-development overhead.
- Multi-region reporting — toggle between USP-format (individual + mean) and EP-format (mean ± SD) reporting.
- Validation package included — IQ/OQ/PQ protocols at no extra cost, not sold separately as the Enterprise brands do.
- SOP lock-down — method parameters locked for routine QC; only designated method-developer users can edit.